A detailed history of Orion Portfolio Solutions, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 6,092 shares of BIIB stock, worth $907,829. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,092
Previous 7,329 16.88%
Holding current value
$907,829
Previous $1.7 Million 30.55%
% of portfolio
0.01%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$189.07 - $236.8 $233,879 - $292,921
-1,237 Reduced 16.88%
6,092 $1.18 Million
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $26,672 - $33,140
140 Added 1.95%
7,329 $1.7 Million
Q1 2024

May 09, 2024

SELL
$212.02 - $267.71 $281,138 - $354,983
-1,326 Reduced 15.57%
7,189 $1.55 Million
Q4 2023

Feb 09, 2024

SELL
$222.59 - $267.94 $212,350 - $255,614
-954 Reduced 10.07%
8,515 $2.2 Million
Q3 2023

Nov 01, 2023

BUY
$253.3 - $285.89 $80,042 - $90,341
316 Added 3.45%
9,469 $2.43 Million
Q2 2023

Aug 17, 2023

BUY
$275.25 - $318.06 $333,052 - $384,852
1,210 Added 15.23%
9,153 $2.61 Million
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $8,257 - $9,541
-30 Reduced 0.38%
7,943 $2.26 Million
Q1 2023

Aug 30, 2023

SELL
$256.56 - $292.34 $10,775 - $12,278
-42 Reduced 0.46%
9,111 $2.53 Million
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $1.76 Million - $2.01 Million
6,873 Added 624.82%
7,973 $2.22 Million
Q4 2022

Feb 08, 2023

BUY
$252.44 - $306.72 $50,235 - $61,037
199 Added 22.09%
1,100 $304,000
Q3 2022

Nov 09, 2022

SELL
$194.69 - $268.46 $32,513 - $44,832
-167 Reduced 15.64%
901 $241,000
Q2 2022

Jul 14, 2022

SELL
$187.54 - $223.02 $16,315 - $19,402
-87 Reduced 7.53%
1,068 $218,000
Q1 2022

May 19, 2022

SELL
$193.77 - $244.14 $55,224 - $69,579
-285 Reduced 19.79%
1,155 $243,000
Q4 2021

Feb 09, 2022

SELL
$223.92 - $287.77 $79,715 - $102,446
-356 Reduced 19.82%
1,440 $345,000
Q3 2021

Nov 10, 2021

SELL
$282.99 - $369.05 $367,887 - $479,765
-1,300 Reduced 41.99%
1,796 $508,000
Q2 2021

Aug 05, 2021

BUY
$259.0 - $414.71 $422,688 - $676,806
1,632 Added 111.48%
3,096 $1.07 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $13,119 - $15,370
54 Added 3.83%
1,464 $410,000
Q4 2020

Feb 04, 2021

SELL
$236.26 - $355.63 $4,016 - $6,045
-17 Reduced 1.19%
1,410 $345,000
Q3 2020

Nov 13, 2020

BUY
$264.77 - $305.71 $62,485 - $72,147
236 Added 19.82%
1,427 $405,000
Q2 2020

Aug 19, 2020

BUY
$258.66 - $342.55 $27,159 - $35,967
105 Added 9.67%
1,191 $319,000
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $28,229 - $35,809
105 Added 10.7%
1,086 $344,000
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $215,878 - $298,292
981 New
981 $291,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.